Peptides Market Scope
Peptides are naturally occurring biological molecules, it found in all living organisms and play major role in biological activity. Synthesized forms of peptides are formed naturally from the transcription of a sequence of the genetic code, DNA. Peptides are found in every cell and tissue and perform a wide range of essential functions. To achieve good homeostasis it is very important to maintain the appropriate concentration of peptides. The major function of peptide is dependent on the types of amino acids involved in the chain and their sequence. Peptide medicines are effectively used to replace or mimic the functions of naturally occurring peptides or to imitate the ability of peptides to engage targets in a highly potent and selective manner. Few peptide therapies are made by using chemical processes, while rest are produced inside genetically modified cells.
The market study is being classified by Type (Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others) and Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)), by Application (Commercial, Academic Research and Therapeutics) and major geographies with country level break-up.
The global peptides market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Peptides market throughout the predicted period.
Zealand Pharma A/S (Denmark), Tocris Bioscience (England), AnaSpec, Inc. (United States), CSBio (United States), GL Biochem (Shanghai) Ltd. (China), CPC Scientific Inc. (United States), Auspep Pty Ltd. (Australia), Peptides International Inc. (United States), Applied Biological Materials (ABM) Inc. (Canada), Thermo Fisher Scientific (United States) and PolyPeptide Group (Sweden) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Enzo Life Sciences, Inc. (United States), JPT Peptide Technologies (Germany), Abcam (Cambridgeshire), Amgen Inc. (United States) and Aviva Systems Biology Corporation (United States).
AdvanceMarketAnalytics has segmented the market of Global Peptides market by Type, Application and Region.
On the basis of geography, the market of Peptides has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In March 2019, Alexion Pharmaceuticals and Zealand Pharma announced the collaboration to discover and develop novel peptide therapies for mediated diseases. Through this collaboration, Alexion gets exclusive worldwide license, development and commercial rights within the complement pathways.
In Mar 2019, Creative Peptides announced the launch of its new pharmaceutical peptides services and with the extension of the application of peptides into a pharmaceutical research and drug development.
- Development in Manufacturing Technologies of Peptides
- High Demand of Catalog Peptides in Commercial Applications
- Growing Demand of Research and Development Protein-Based Activities
- Increase Burden of Chronic Diseases
- Advancement in Research and Development Industry
- Growing Number of Pharmaceutical and Biotechnology Companies in Asia Pacific Regions
- High Cost of Manufacturing Process
- High Contamination Issues While Peptides Synthesis and Growing Requirement of Drug Development
- Rapid Development in Drug Production Technologies
- Stringent Regulations in Various Regions
Analyst ViewTo study the market, we approach the market from the business side. Major players in peptides are continuously investing in protein research and development sector. The top players in peptides market are enhancing their global foot print in various regions.
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Peptides Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase